International Clinical Trial: Safety, Feasibility, and Preliminary Antitumor Activity of PD-1/PD-L1 Immunotherapy Combined with Controlled Cold Exposure in Patients with Solid Tumors

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122732) titled 'Safety, Feasibility, and Preliminary Antitumor Activity of PD-1/PD-L1 Immunotherapy Combined with Controlled Cold Exposure in Patients with Solid Tumors' on April 16.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: West China Hospital, Sichuan University

Condition: Solid Tumor

Intervention: Mild Cold Exposure Plus Standard PD-1/PD-L1 Therapy Arm:Standard PD-1/PD-L1 inhibitor monotherapy or standard combination regimens containing PD-1/PD-L1 inhibitors

Recruitment Status: Not Recruiting

Phase: 1

Date of First Enrollment: 2026-04-20

Target Sample Size: Mild Cold Exposure Pl...